查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1460101

週边神经刺激器市场预测：~2030年

Peripheral Nerve Stimulator Market Research Report Forecast till 2030
出版日期: | 出版商: Market Research Future | 英文 124 Pages | 订单完成后即时交付

价格

全球週边神经刺激器市场规模预计在预测期内复合年增长率为 6.65%。 由于人们对远端週边神经刺激器的兴趣增加，该市场正在成长。

北美区域市场前景广阔，市场发展可期。 对医疗基础设施的兴趣和对尖端临床安排的认识不断提高可能会推动市场的进一步成长。 此外，由于技术创新的进步、医疗服务的扩大和病例数量的增加，欧洲市场占整个产业的第二大占有率。 此外，由于人口众多、神经血管感染数量不断增加以及良好的管理策略，亚太市场预计将成为最大的市场。 此外，活跃在全球週边神经刺激器市场的主要公司有效地存在于该地区，进一步促进了该地区市场的发展。

本报告调查了全球週边神经刺激器市场，提供了市场的定义和概述，分析了影响市场成长和市场机会的因素、市场规模的趋势和预测，并依各个细分市场和地区进行了细分。

目录

第 1 章执行摘要

第 2 章执行摘要

第三章市场概述

第四章研究方法

第五章市场动态

  • 摘要
  • 促进因素
    • 对週边神经刺激器的需求不断增加
    • 神经损伤加剧
    • 对无线週边神经刺激器的需求不断增加
  • 抑制因素
    • 缺乏设备安装和控制的技术技能
    • 与週边神经刺激器相关的高成本
  • 机会
    • 科技进步的发展

第六章市场因素分析

  • 价值链分析
  • 波特五力分析
  • COVID-19 对全球週边神经刺激器市场的影响

第 7 章全球週边神经刺激器市场：依产品

  • 摘要
  • 经皮法
  • 经皮法
  • 嵌入式

第 8 章全球週边神经刺激器市场：依设备类型

  • 摘要
  • 刺激器
  • CPNB 导管
  • 止痛泵
  • 其他

第 9 章全球週边神经刺激器市场：依刺激特征

  • 摘要
  • 具有四重 (TOF) 监测功能的刺激器
  • 不含TOF功能的机器

第 10 章全球週边神经刺激器市场：依最终使用者划分

  • 摘要
  • 医院/诊所
  • 门诊手术中心
  • 其他

第 11 章全球週边神经刺激器市场：依地区

  • 摘要
  • 北美
  • 欧洲
  • 亚太地区
  • 其他领域

第十二章公司简介

  • 摘要
  • 竞争基准测试
  • 主要成长策略
  • 开发专案数量最多的公司
  • 主要发展分析
  • 主要发展/成长策略
  • 财务矩阵

第十三章公司简介

  • MEDTRONIC
  • B. BRAUN SE
  • BOSTON SCIENTIFIC CORPORATION
  • CURONIX LLC
  • SPR THERAPEUTICS
  • AVNS
  • TELEFLEX INCORPORATED
  • SUNMED
  • XAVANT TECHNOLOGY（PTY）LTD
  • VYGON

第14章附录

Product Code: MRFR/HC/6584-CR

Peripheral Nerve Stimulator Market Research Report Forecast till 2032

Download PDF

Market Overview

Global Peripheral Nerve Stimulators market is anticipated to register a CAGR of 6.65% during the review period. The Worldwide Peripheral Nerve Stimulators market is encountering a development because of the rising interest for Remote Peripheral Nerve Stimulators. This inclination for cutting edge, remote arrangements in neuromodulation is driving the market forward and showing an extraordinary pattern in medical care. The flood popular features the significant development direction of the market.

The Peripheral nerve feeling as often as possible alluded to as PNS, is a normally utilized way to deal with treat persistent agony. The development of the peripheral nerve stimulators market is ascribed to the rising interest for peripheral nerve stimulators, ascend in instances of nerve wounds, and the developing interest for remote peripheral nerve stimulators. In any case, the absence of specialized abilities for establishment and control of a gadget, and the significant expense related with the peripheral nerve stimulators gadgets is expected to hamper the market development.

The utilization of oral prescriptions like Pamelor, Sinequan, and Elavil in neurological turmoil patients is related with destructive aftereffects and may likewise prompt dependence on drugs. Consequently, the peripheral nerve stimulator is profoundly liked as an elective agony control choice as it gives compelling treatment over oral meds. It decreases the utilization of opiate sedates and can be embedded in patients which permits them to play out their nonimpact sporting exercises like swimming. The Public Organization of Neurological Issues and Stroke reports that around 50 million Americans are impacted by roughly 600 neurologic problems every year. Neuropathic torment is a pervasive medical problem in most industrialized countries, affecting generally 40%-60% of the old populace and grown-ups around the world.

Market Segmentation

The Global Peripheral Nerve Stimulators segmentation, based on products, includes transcutaneous, percutaneous, and implantable.

Based on device type the market is classified into stimulators, continuous peripheral nerve blocks (CPNB) catheters, and pain pumps.

Based on stimulating machines the Global Peripheral Nerve Stimulators market is divided into stimulator machines with train of four (TOF) monitoring features and machines without TOF features. The end use segment is segmented into hospitals & clinics, ambulatory surgery centers, and others.

Region Insights

The viewpoint for the North America Peripheral Nerve Stimulators market stays promising, with supported development expected. Interests in medical care foundation and a developing consciousness of cutting-edge clinical arrangements are supposed to drive market extension further. Both laid out players and arising contestants are ready to exploit these valuable open doors, utilizing mechanical progressions to satisfy the rising need for further developed nerve stimulators results.

Europe Peripheral Nerve Stimulators market represented the second-biggest portion of the overall industry because of innovation progressions, expanding medical services use, and expanding instances of nerve wounds.

The Asia-Pacific Peripheral Nerve Stimulators market is attributable to register a biggest market owing to a high quiet populace, rising number neurovascular infections, and good administrative strategies. Besides, central members working in the Worldwide Peripheral Nerve Stimulators market are effectively venturing into this region, further driving the regional market development.

Major Players

The major companies operating in the Peripheral Nerve Stimulators in market are Braun SE (Germany), MEDTRONIC (Ireland), Boston Scientific Corporation (US), SPR Therapeutics (US), AVNS (US), Teleflex Incorporated (US), Curonix LLC (US), SUNMED (US), Xavant Technology (Pty) Ltd (South Africa), and Vygon (France).

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 EXECUTIVE SUMMARY

  • 2.1 OVERVIEW

3 MARKET INTRODUCTION

  • 3.1 DEFINITION
  • 3.2 SCOPE OF THE STUDY
  • 3.3 RESEARCH OBJECTIVE
  • 3.4 MARKET STRUCTURE
  • 3.5 ASSUMPTIONS & LIMITATIONS

4 RESEARCH METHODOLOGY

  • 4.1 DATA MINING
  • 4.2 SECONDARY RESEARCH
  • 4.3 PRIMARY RESEARCH
  • 4.4 BREAKDOWN OF PRIMARY RESPONDENTS
  • 4.5 FORECASTING TECHNIQUES
  • 4.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
    • 4.6.1 BOTTOM-UP APPROACH
    • 4.6.2 TOP-DOWN APPROACH
  • 4.7 DATA TRIANGULATION
  • 4.8 VALIDATION

5 MARKET DYNAMICS

  • 5.1 OVERVIEW
  • 5.2 DRIVERS
    • 5.2.1 INCREASING DEMAND FOR PERIPHERAL NERVE STIMULATORS
    • 5.2.2 RISE IN CASES OF NERVE INJURIES
    • 5.2.3 GROWING DEMAND FOR WIRELESS PERIPHERAL NERVE STIMULATORS
  • 5.3 RESTRAINTS
    • 5.3.1 LACK OF TECHNICAL SKILLS FOR INSTALLATION AND CONTROL OF A DEVICE
    • 5.3.2 HIGH COST ASSOCIATED WITH THE PERIPHERAL NERVE STIMULATORS DEVICES
  • 5.4 OPPORTUNITIES
    • 5.4.1 GROWING TECHNOLOGICAL ADVANCEMENTS

6 MARKET FACTOR ANALYSIS

  • 6.1 VALUE CHAIN ANALYSIS
    • 6.1.1 R&D & DESIGNING
    • 6.1.2 MANUFACTURING
    • 6.1.3 DISTRIBUTION & SALES
    • 6.1.4 POST-SALES MONITORING
  • 6.2 PORTER'S FIVE FORCES MODEL
    • 6.2.1 THREAT OF NEW ENTRANTS
    • 6.2.2 BARGAINING POWER OF SUPPLIERS
    • 6.2.3 THREAT OF SUBSTITUTES
    • 6.2.4 BARGAINING POWER OF BUYERS
    • 6.2.5 INTENSITY OF RIVALRY
  • 6.3 IMPACT OF COVID-19 ON THE GLOBAL PERIPHERAL NERVE STIMULATORS MARKET
    • 6.3.1 IMPACT ON SUPPLY CHAIN
    • 6.3.2 IMPACT ON PRICING
    • 6.3.1 IMPACT ON REGIONS
    • 6.3.2 IMPACT ON PRODUCTION
    • 6.3.3 IMPACT ON DEMAND-SUPPLY GAP

7 GLOBAL PERIPHERAL NERVE STIMULATORS MARKET, BY PRODUCT

  • 7.1 OVERVIEW
  • 7.2 TRANSCUTANEOUS
  • 7.3 PERCUTANEOUS
  • 7.4 IMPLANTABLE

8 GLOBAL PERIPHERAL NERVE STIMULATORS MARKET, BY DEVICE TYPE

  • 8.1 OVERVIEW
  • 8.2 STIMULATORS
  • 8.3 CPNB CATHETERS
  • 8.4 PAIN PUMPS
  • 8.5 OTHERS

9 GLOBAL PERIPHERAL NERVE STIMULATORS MARKET, BY STIMULATING FEATURE

  • 9.1 OVERVIEW
  • 9.2 STIMULATOR MACHINES WITH TRAIN OF FOUR (TOF) MONITORING FEATURES
  • 9.3 MACHINES WITHOUT TOF FEATURES

10 GLOBAL PERIPHERAL NERVE STIMULATORS MARKET, BY END USER

  • 10.1 OVERVIEW
  • 10.2 HOSPITAL & CLINICS
  • 10.3 AMBULATORY SURGERY CENTERS
  • 10.4 OTHERS

11 GLOBAL PERIPHERAL NERVE STIMULATORS MARKET, BY REGION

  • 11.1 OVERVIEW
  • 11.2 NORTH AMERICA
    • 11.2.1 NORTH AMERICA
    • 11.2.2 US
    • 11.2.3 CANADA
  • 11.3 EUROPE
    • 11.3.1 GERMANY
    • 11.3.2 FRANCE
    • 11.3.3 UK
    • 11.3.4 ITALY
    • 11.3.5 SPAIN
    • 11.3.6 REST OF EUROPE
  • 11.4 ASIA-PACIFIC
    • 11.4.1 CHINA
    • 11.4.2 INDIA
    • 11.4.3 JAPAN
    • 11.4.4 SOUTH KOREA
    • 11.4.5 AUSTRALIA
    • 11.4.6 REST OF ASIA-PACIFIC
  • 11.5 REST OF THE WORLD
    • 11.5.1 MIDDLE EAST
    • 11.5.2 AFRICA
    • 11.5.3 LATIN AMERICA
  • 12.1 OVERVIEW
  • 12.2 COMPETITIVE BENCHMARKING
  • 12.3 MAJOR GROWTH STRATEGY IN THE GLOBAL PERIPHERAL NERVE STIMULATORS MARKET
  • 12.4 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE GLOBAL PERIPHERAL NERVE STIMULATORS MARKET
  • 12.5 KEY DEVELOPMENT ANALYSIS
  • 12.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
    • 12.6.1 PRODUCT APPROVAL AND PRODUCT LAUNCH
  • 12.7 FINANCIAL MATRIX
    • 12.7.1 SALES (USD MILLION), 2021
    • 12.7.2 RESEARCH & DEVELOPMENT EXPENDITURE (USD MILLION), 2021

13 COMPANY PROFILES

  • 13.1 MEDTRONIC
    • 13.1.1 COMPANY OVERVIEW
    • 13.1.2 FINANCIAL OVERVIEW
    • 13.1.3 PRODUCTS OFFERED
    • 13.1.4 KEY DEVELOPMENTS
    • 13.1.5 SWOT ANALYSIS
    • 13.1.6 KEY STRATEGIES
  • 13.2 B. BRAUN SE
    • 13.2.1 COMPANY OVERVIEW
    • 13.2.2 FINANCIAL OVERVIEW
    • 13.2.3 PRODUCTS OFFERED
    • 13.2.4 KEY DEVELOPMENTS
    • 13.2.5 SWOT ANALYSIS
    • 13.2.6 KEY STRATEGIES
  • 13.3 BOSTON SCIENTIFIC CORPORATION
    • 13.3.1 COMPANY OVERVIEW
    • 13.3.2 FINANCIAL OVERVIEW
    • 13.3.3 PRODUCTS OFFERED
    • 13.3.4 KEY DEVELOPMENTS
    • 13.3.5 SWOT ANALYSIS
    • 13.3.6 KEY STRATEGIES
  • 13.4 CURONIX LLC
    • 13.4.1 COMPANY OVERVIEW
    • 13.4.2 FINANCIAL OVERVIEW
    • 13.4.3 PRODUCTS OFFERED
    • 13.4.4 KEY DEVELOPMENTS
    • 13.4.5 KEY STRATEGIES
  • 13.5 SPR THERAPEUTICS
    • 13.5.1 COMPANY OVERVIEW
    • 13.5.2 FINANCIAL OVERVIEW
    • 13.5.3 PRODUCTS OFFERED
    • 13.5.4 KEY DEVELOPMENTS
    • 13.5.5 KEY STRATEGIES
  • 13.6 AVNS
    • 13.6.1 COMPANY OVERVIEW
    • 13.6.2 FINANCIAL OVERVIEW
    • 13.6.3 PRODUCTS OFFERED
    • 13.6.4 KEY DEVELOPMENTS
    • 13.6.5 SWOT ANALYSIS
    • 13.6.6 KEY STRATEGIES
  • 13.7 TELEFLEX INCORPORATED
    • 13.7.1 COMPANY OVERVIEW
    • 13.7.2 FINANCIAL OVERVIEW
    • 13.7.3 PRODUCTS OFFERED
    • 13.7.4 KEY DEVELOPMENTS
    • 13.7.5 SWOT ANALYSIS
    • 13.7.6 KEY STRATEGIES
  • 13.8 SUNMED
    • 13.8.1 COMPANY OVERVIEWS
    • 13.8.2 FINANCIAL OVERVIEW
    • 13.8.3 PRODUCTS OFFERED
    • 13.8.4 KEY DEVELOPMENTS
    • 13.8.5 KEY STRATEGIES
  • 13.9 XAVANT TECHNOLOGY (PTY) LTD
    • 13.9.1 COMPANY OVERVIEW
    • 13.9.2 FINANCIAL OVERVIEW
    • 13.9.3 PRODUCTS OFFERED
    • 13.9.4 KEY DEVELOPMENTS
    • 13.9.5 KEY STRATEGIES
  • 13.10 VYGON
    • 13.10.1 COMPANY OVERVIEW
    • 13.10.2 FINANCIAL OVERVIEW
    • 13.10.3 PRODUCTS OFFERED
    • 13.10.4 KEY DEVELOPMENTSS
    • 13.10.5 KEY STRATEGIES

14 APPENDIX

  • 14.1 REFERENCES
  • 14.2 THE FOUNDATION FOR PERIPHERAL NEUROPATHY
  • 14.3 PERIPHERAL NERVE SOCIETY (PNS)
  • 14.4 AMERICAN NEUROLOGICAL ASSOCIATION (ANA)
  • 14.5 AMERICAN ASSOCIATION OF NEUROLOGICAL SURGEONS
  • 14.6 AMERICAN SOCIETY FOR PERIPHERAL NERVE (ASPN)
  • 14.7 BRITISH PERIPHERAL NERVE SOCIETY (BPNS)
  • 14.8 PAN AFRICAN ASSOCIATION OF NEUROLOGICAL SCIENCES (PAANS)
  • 14.9 THE NEUROLOGICAL ASSOCIATION OF SOUTH AFRICA (NASA)
  • 4.12 RELATED REPORTS

LIST OF TABLES

  • TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS
  • TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
  • TABLE 3 GLOBAL PERIPHERAL NERVE STIMULATORS MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 4 GLOBAL PERIPHERAL NERVE STIMULATORS MARKET, FOR TRANSCUTANEOUS, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 5 GLOBAL PERIPHERAL NERVE STIMULATORS MARKET, FOR PERCUTANEOUS, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 6 GLOBAL PERIPHERAL NERVE STIMULATORS MARKET, FOR IMPLANTABLE, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 7 GLOBAL PERIPHERAL NERVE STIMULATORS MARKET, BY DEVICE TYPE, 2019-2030 (USD MILLION)
  • TABLE 8 GLOBAL PERIPHERAL NERVE STIMULATORS MARKET, FOR STIMULATORS, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 9 GLOBAL PERIPHERAL NERVE STIMULATORS MARKET, FOR CPNB CATHETERS, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 10 GLOBAL PERIPHERAL NERVE STIMULATORS MARKET, FOR PAIN PUMPS, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 11 GLOBAL PERIPHERAL NERVE STIMULATORS MARKET, FOR OTHERS, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 12 GLOBAL PERIPHERAL NERVE STIMULATORS MARKET, BY STIMULATING FEATURE, 2019-2030 (USD MILLION)
  • TABLE 13 GLOBAL PERIPHERAL NERVE STIMULATORS MARKET, FOR STIMULATOR MACHINES WITH TRAIN OF FOUR (TOF) MONITORING FEATURES, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 14 GLOBAL PERIPHERAL NERVE STIMULATORS MARKET, FOR MACHINES WITHOUT TOF FEATURES, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 15 GLOBAL PERIPHERAL NERVE STIMULATORS MARKET, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 16 GLOBAL PERIPHERAL NERVE STIMULATORS MARKET, FOR HOSPITALS & CLINICS, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 17 GLOBAL PERIPHERAL NERVE STIMULATORS MARKET, FOR AMBULATORY SURGERY CENTERS, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 18 GLOBAL PERIPHERAL NERVE STIMULATORS MARKET, FOR OTHERS, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 19 GLOBAL PERIPHERAL NERVE STIMULATORS MARKET, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 20 GLOBAL: PERIPHERAL NERVE STIMULATORS MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 21 GLOBAL: PERIPHERAL NERVE STIMULATORS MARKET, BY DEVICE TYPE, 2019-2030 (USD MILLION)
  • TABLE 22 GLOBAL: PERIPHERAL NERVE STIMULATORS MARKET, BY STIMULATING FEATURE, 2019-2030 (USD MILLION)
  • TABLE 23 GLOBAL: PERIPHERAL NERVE STIMULATORS MARKET, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 24 NORTH AMERICA: PERIPHERAL NERVE STIMULATORS MARKET, BY COUNTRY, 2019-2030 (USD MILLION)
  • TABLE 25 NORTH AMERICA: PERIPHERAL NERVE STIMULATORS MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 26 NORTH AMERICA: PERIPHERAL NERVE STIMULATORS MARKET, BY DEVICE TYPE, 2019-2030 (USD MILLION)
  • TABLE 27 NORTH AMERICA: PERIPHERAL NERVE STIMULATORS MARKET, BY STIMULATING FEATURE, 2019-2030 (USD MILLION)
  • TABLE 28 NORTH AMERICA: PERIPHERAL NERVE STIMULATORS MARKET, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 29 US: PERIPHERAL NERVE STIMULATORS MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 30 US: PERIPHERAL NERVE STIMULATORS MARKET, BY DEVICE TYPE, 2019-2030 (USD MILLION)
  • TABLE 31 US: PERIPHERAL NERVE STIMULATORS MARKET, BY STIMULATING FEATURE, 2019-2030 (USD MILLION)
  • TABLE 32 US: PERIPHERAL NERVE STIMULATORS MARKET, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 33 CANADA: PERIPHERAL NERVE STIMULATORS MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 34 CANADA: PERIPHERAL NERVE STIMULATORS MARKET, BY DEVICE TYPE, 2019-2030 (USD MILLION)
  • TABLE 35 CANADA: PERIPHERAL NERVE STIMULATORS MARKET, BY STIMULATING FEATURE, 2019-2030 (USD MILLION)
  • TABLE 36 CANADA: PERIPHERAL NERVE STIMULATORS MARKET, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 37 EUROPE: PERIPHERAL NERVE STIMULATORS MARKET, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 38 EUROPE: PERIPHERAL NERVE STIMULATORS MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 39 EUROPE: PERIPHERAL NERVE STIMULATORS MARKET BY DEVICE TYPE, 2019-2030 (USD MILLION)
  • TABLE 40 EUROPE: PERIPHERAL NERVE STIMULATORS MARKET, BY STIMULATING FEATURE, 2019-2030 (USD MILLION)
  • TABLE 41 EUROPE: PERIPHERAL NERVE STIMULATORS MARKET, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 42 GERMANY: PERIPHERAL NERVE STIMULATORS MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 43 GERMANY: PERIPHERAL NERVE STIMULATORS MARKET BY DEVICE TYPE, 2019-2030 (USD MILLION)
  • TABLE 44 GERMANY: PERIPHERAL NERVE STIMULATORS MARKET, BY STIMULATING FEATURE, 2019-2030 (USD MILLION)
  • TABLE 45 GERMANY: PERIPHERAL NERVE STIMULATORS MARKET, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 46 FRANCE: PERIPHERAL NERVE STIMULATORS MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 47 FRANCE: PERIPHERAL NERVE STIMULATORS MARKET BY DEVICE TYPE, 2019-2030 (USD MILLION)
  • TABLE 48 FRANCE: PERIPHERAL NERVE STIMULATORS MARKET, BY STIMULATING FEATURE, 2019-2030 (USD MILLION)
  • TABLE 49 FRANCE: PERIPHERAL NERVE STIMULATORS MARKET, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 50 UK: PERIPHERAL NERVE STIMULATORS MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 51 UK: PERIPHERAL NERVE STIMULATORS MARKET BY DEVICE TYPE, 2019-2030 (USD MILLION)
  • TABLE 52 UK: PERIPHERAL NERVE STIMULATORS MARKET, BY STIMULATING FEATURE, 2019-2030 (USD MILLION)
  • TABLE 53 UK: PERIPHERAL NERVE STIMULATORS MARKET, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 54 ITALY: PERIPHERAL NERVE STIMULATORS MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 55 ITALY: PERIPHERAL NERVE STIMULATORS MARKET BY DEVICE TYPE, 2019-2030 (USD MILLION)
  • TABLE 56 ITALY: PERIPHERAL NERVE STIMULATORS MARKET, BY STIMULATING FEATURE, 2019-2030 (USD MILLION)
  • TABLE 57 ITALY: PERIPHERAL NERVE STIMULATORS MARKET, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 58 SPAIN: PERIPHERAL NERVE STIMULATORS MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 59 SPAIN: PERIPHERAL NERVE STIMULATORS MARKET BY DEVICE TYPE, 2019-2030 (USD MILLION)
  • TABLE 60 SPAIN: PERIPHERAL NERVE STIMULATORS MARKET, BY STIMULATING FEATURE, 2019-2030 (USD MILLION)
  • TABLE 61 SPAIN: PERIPHERAL NERVE STIMULATORS MARKET, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 62 REST OF EUROPE: PERIPHERAL NERVE STIMULATORS MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 63 REST OF EUROPE: PERIPHERAL NERVE STIMULATORS MARKET BY DEVICE TYPE, 2019-2030 (USD MILLION)
  • TABLE 64 REST OF EUROPE: PERIPHERAL NERVE STIMULATORS MARKET, BY STIMULATING FEATURE, 2019-2030 (USD MILLION)
  • TABLE 65 REST OF EUROPE: PERIPHERAL NERVE STIMULATORS MARKET, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 66 ASIA-PACIFIC: PERIPHERAL NERVE STIMULATORS MARKET, BY COUNTRY, 2019-2030 (USD MILLION)
  • TABLE 67 ASIA-PACIFIC: PERIPHERAL NERVE STIMULATORS MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 68 ASIA-PACIFIC: PERIPHERAL NERVE STIMULATORS MARKET, BY DEVICE TYPE, 2019-2030 (USD MILLION)
  • TABLE 69 ASIA-PACIFIC: PERIPHERAL NERVE STIMULATORS MARKET, BY STIMULATING FEATURE, 2019-2030 (USD MILLION)
  • TABLE 70 ASIA-PACIFIC: PERIPHERAL NERVE STIMULATORS MARKET, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 71 CHINA: PERIPHERAL NERVE STIMULATORS MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 72 CHINA: PERIPHERAL NERVE STIMULATORS MARKET, BY DEVICE TYPE, 2019-2030 (USD MILLION)
  • TABLE 73 CHINA: PERIPHERAL NERVE STIMULATORS MARKET, BY STIMULATING FEATURE, 2019-2030 (USD MILLION)
  • TABLE 74 CHINA: PERIPHERAL NERVE STIMULATORS MARKET, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 75 INDIA: PERIPHERAL NERVE STIMULATORS MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 76 INDIA: PERIPHERAL NERVE STIMULATORS MARKET, BY DEVICE TYPE, 2019-2030 (USD MILLION)
  • TABLE 77 INDIA: PERIPHERAL NERVE STIMULATORS MARKET, BY STIMULATING FEATURE, 2019-2030 (USD MILLION)
  • TABLE 78 INDIA: PERIPHERAL NERVE STIMULATORS MARKET, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 79 JAPAN: PERIPHERAL NERVE STIMULATORS MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 80 JAPAN: PERIPHERAL NERVE STIMULATORS MARKET, BY DEVICE TYPE, 2019-2030 (USD MILLION)
  • TABLE 81 JAPAN: PERIPHERAL NERVE STIMULATORS MARKET, BY STIMULATING FEATURE, 2019-2030 (USD MILLION)
  • TABLE 82 JAPAN: PERIPHERAL NERVE STIMULATORS MARKET, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 83 SOUTH KOREA: PERIPHERAL NERVE STIMULATORS MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 84 SOUTH KOREA: PERIPHERAL NERVE STIMULATORS MARKET, BY DEVICE TYPE, 2019-2030 (USD MILLION)
  • TABLE 85 SOUTH KOREA: PERIPHERAL NERVE STIMULATORS MARKET, BY STIMULATING FEATURE, 2019-2030 (USD MILLION)
  • TABLE 86 SOUTH KOREA: PERIPHERAL NERVE STIMULATORS MARKET, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 87 AUSTRALIA: PERIPHERAL NERVE STIMULATORS MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 88 AUSTRALIA: PERIPHERAL NERVE STIMULATORS MARKET, BY DEVICE TYPE, 2019-2030 (USD MILLION)
  • TABLE 89 AUSTRALIA: PERIPHERAL NERVE STIMULATORS MARKET, BY STIMULATING FEATURE, 2019-2030 (USD MILLION)
  • TABLE 90 AUSTRALIA: PERIPHERAL NERVE STIMULATORS MARKET, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 91 REST OF ASIA-PACIFIC: PERIPHERAL NERVE STIMULATORS MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 92 REST OF ASIA-PACIFIC: PERIPHERAL NERVE STIMULATORS MARKET, BY DEVICE TYPE, 2019-2030 (USD MILLION)
  • TABLE 93 REST OF ASIA-PACIFIC: PERIPHERAL NERVE STIMULATORS MARKET, BY STIMULATING FEATURE, 2019-2030 (USD MILLION)
  • TABLE 94 REST OF ASIA-PACIFIC: PERIPHERAL NERVE STIMULATORS MARKET, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 1 REST OF THE WORLD: PERIPHERAL NERVE STIMULATORS MARKET, BY COUNTRY, 2019-2030 (USD MILLION)
  • TABLE 2 REST OF THE WORLD: PERIPHERAL NERVE STIMULATORS MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 3 REST OF THE WORLD: PERIPHERAL NERVE STIMULATORS MARKET, BY DEVICE TYPE, 2019-2030 (USD MILLION)
  • TABLE 4 REST OF THE WORLD: PERIPHERAL NERVE STIMULATORS MARKET, BY STIMULATING FEATURE, 2019-2030 (USD MILLION)
  • TABLE 5 REST OF THE WORLD: PERIPHERAL NERVE STIMULATORS MARKET, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 6 MIDDLE EAST: PERIPHERAL NERVE STIMULATORS MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 7 MIDDLE EAST: PERIPHERAL NERVE STIMULATORS MARKET, BY DEVICE TYPE, 2019-2030 (USD MILLION)
  • TABLE 8 MIDDLE EAST: PERIPHERAL NERVE STIMULATORS MARKET, BY STIMULATING FEATURE, 2019-2030 (USD MILLION)
  • TABLE 9 MIDDLE EAST: PERIPHERAL NERVE STIMULATORS MARKET, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 10 AFRICA: PERIPHERAL NERVE STIMULATORS MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 11 AFRICA: PERIPHERAL NERVE STIMULATORS MARKET, BY DEVICE TYPE, 2019-2030 (USD MILLION)
  • TABLE 12 AFRICA: PERIPHERAL NERVE STIMULATORS MARKET, BY STIMULATING FEATURE, 2019-2030 (USD MILLION)
  • TABLE 13 AFRICA: PERIPHERAL NERVE STIMULATORS MARKET, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 14 LATIN AMERICA: PERIPHERAL NERVE STIMULATORS MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 15 LATIN AMERICA: PERIPHERAL NERVE STIMULATORS MARKET, BY DEVICE TYPE, 2019-2030 (USD MILLION)
  • TABLE 16 LATIN AMERICA: PERIPHERAL NERVE STIMULATORS MARKET, BY STIMULATING FEATURE, 2019-2030 (USD MILLION)
  • TABLE 17 LATIN AMERICA: PERIPHERAL NERVE STIMULATORS MARKET, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 18 MAJOR PLAYERS IN THE GLOBAL PERIPHERAL NERVE STIMULATORS MARKET
  • TABLE 19 BENCHMARKING OF MAJOR COMPETITORS
  • TABLE 20 MOST ACTIVE PLAYER IN THE GLOBAL PERIPHERAL NERVE STIMULATORS MARKET
  • TABLE 21 PRODUCT APPROVAL AND PRODUCT LAUNCH: GLOBAL PERIPHERAL NERVE STIMULATORS MARKET
  • TABLE 22 MEDTRONIC: PRODUCTS OFFERED
  • TABLE 23 MEDTRONIC: KEY DEVELOPMENTS
  • TABLE 24 B. BRAUN SE: PRODUCTS OFFERED
  • TABLE 25 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED
  • TABLE 26 BOSTON SCIENTIFIC CORPORATION: KEY DEVELOPMENTS
  • TABLE 27 CURONIX LLC: PRODUCTS OFFERED
  • TABLE 28 SPR THERAPEUTICS: PRODUCTS OFFERED
  • TABLE 29 SPR THERAPEUTICS: KEY DEVELOPMENTS
  • TABLE 30 AVNS: PRODUCTS OFFERED
  • TABLE 31 TELEFLEX INCORPORATED: PRODUCTS OFFERED
  • TABLE 32 SUNMED: PRODUCTS OFFERED
  • TABLE 33 XAVANT TECHNOLOGY (PTY) LTD: PRODUCTS OFFERED
  • TABLE 34 XAVANT TECHNOLOGY (PTY) LTD: KEY DEVELOPMENTS
  • TABLE 35 VYGON: PRODUCTS OFFERED

LIST OF FIGURES

  • FIGURE 1 MARKET SYNOPSIS
  • FIGURE 2 GLOBAL PERIPHERAL NERVE STIMULATORS MARKET
  • FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES
  • FIGURE 4 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL PERIPHERAL NERVE STIMULATORS MARKET
  • FIGURE 5 DRIVER IMPACT ANALYSIS
  • FIGURE 6 RESTRAINT IMPACT ANALYSIS
  • FIGURE 7 VALUE CHAIN ANALYSIS: GLOBAL PERIPHERAL NERVE STIMULATORS MARKET
  • FIGURE 8 PORTER'S FIVE FORCES ANALYSIS: GLOBAL PERIPHERAL NERVE STIMULATORS MARKET
  • FIGURE 9 GLOBAL PERIPHERAL NERVE STIMULATORS MARKET, PRODUCT SEGMENT ATTRACTIVENESS, (USD MILLION)
  • FIGURE 10 GLOBAL PERIPHERAL NERVE STIMULATORS MARKET, BY PRODUCT, 2022 & 2030 (USD MILLION)
  • FIGURE 11 GLOBAL PERIPHERAL NERVE STIMULATORS MARKET SHARE (%), BY PRODUCT, 2022
  • FIGURE 12 GLOBAL PERIPHERAL NERVE STIMULATORS MARKET, DEVICE TYPE SEGMENT ATTRACTIVENESS, (USD MILLION)
  • FIGURE 13 GLOBAL PERIPHERAL NERVE STIMULATORS MARKET, BY DEVICE TYPE, 2022 & 2030 (USD MILLION)
  • FIGURE 14 GLOBAL PERIPHERAL NERVE STIMULATORS MARKET SHARE (%), BY DEVICE TYPE, 2022
  • FIGURE 15 GLOBAL PERIPHERAL NERVE STIMULATORS MARKET, STIMULATING FEATURE SEGMENT ATTRACTIVENESS, (USD MILLION)
  • FIGURE 16 GLOBAL PERIPHERAL NERVE STIMULATORS MARKET, BY STIMULATING FEATURE, 2022 & 2030 (USD MILLION)
  • FIGURE 17 GLOBAL PERIPHERAL NERVE STIMULATORS MARKET SHARE (%), BY STIMULATING FEATURE, 2022
  • FIGURE 18 GLOBAL PERIPHERAL NERVE STIMULATORS MARKET, END USER SEGMENT ATTRACTIVENESS, (USD MILLION)
  • FIGURE 19 GLOBAL PERIPHERAL NERVE STIMULATORS MARKET, BY END USER, 2022 & 2030 (USD MILLION)
  • FIGURE 20 GLOBAL PERIPHERAL NERVE STIMULATORS MARKET SHARE (%), BY END USER, 2022
  • FIGURE 21 GLOBAL PERIPHERAL NERVE STIMULATORS MARKET, BY REGION, 2021 & 2030 (USD MILLION)
  • FIGURE 22 GLOBAL PERIPHERAL NERVE STIMULATORS MARKET SHARE, BY REGION, 2021 (%)
  • FIGURE 23 NORTH AMERICA MARKET ANALYSIS: PERIPHERAL NERVE STIMULATORS MARKET, 2019-2030 (USD MILLION)
  • FIGURE 24 NORTH AMERICA: PERIPHERAL NERVE STIMULATORS MARKET, BY COUNTRY, 2021 & 2030 (USD MILLION)
  • FIGURE 25 NORTH AMERICA: PERIPHERAL NERVE STIMULATORS MARKET SHARE, BY COUNTRY 2021 (%)
  • FIGURE 26 EUROPE MARKET ANALYSIS: PERIPHERAL NERVE STIMULATORS MARKET, 2019-2030 (USD MILLION)
  • FIGURE 27 EUROPE: PERIPHERAL NERVE STIMULATORS MARKET SHARE (%), BY REGION 2022
  • FIGURE 28 EUROPE: PERIPHERAL NERVE STIMULATORS MARKET, BY REGION 2022 & 2030 (USD MILLION)
  • FIGURE 29 ASIA-PACIFIC MARKET ANALYSIS: PERIPHERAL NERVE STIMULATORS MARKET, 2019-2030 (USD MILLION)
  • FIGURE 30 ASIA-PACIFIC: PERIPHERAL NERVE STIMULATORS MARKET SHARE (%), BY COUNTRY, 2022
  • FIGURE 31 ASIA-PACIFIC: PERIPHERAL NERVE STIMULATORS MARKET, BY COUNTRY, 2022 & 2030 (USD MILLION)
  • FIGURE 32 REST OF THE WORLD MARKET ANALYSIS: PERIPHERAL NERVE STIMULATORS MARKET, 2019-2030 (USD MILLION)
  • FIGURE 1 REST OF THE WORLD: PERIPHERAL NERVE STIMULATORS MARKET, BY COUNTRY, 2022 & 2030
  • FIGURE 2 REST OF THE WORLD: PERIPHERAL NERVE STIMULATORS MARKET SHARE (%), BY REGION, 2022
  • FIGURE 3 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL PERIPHERAL NERVE STIMULATORS MARKET
  • FIGURE 4 GLOBAL PERIPHERAL NERVE STIMULATORS MARKET: COMPETITIVE LANDSCAPE
  • FIGURE 5 SALES 2021
  • FIGURE 6 RESEARCH & DEVELOPMENT EXPENDITURE, 2021
  • FIGURE 7 MEDTRONIC: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 8 MEDTRONIC SWOT ANALYSIS
  • FIGURE 9 B. BRAUN SE: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 10 B. BRAUN SE: SWOT ANALYSIS
  • FIGURE 11 BOSTON SCIENTIFIC CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 12 BOSTON SCIENTIFIC CORPORATION: SWOT ANALYSIS
  • FIGURE 13 AVNS: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 14 AVNS: SWOT ANALYSIS
  • FIGURE 15 TELEFLEX INCORPORATED: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 16 TELEFLEX INCORPORATED: SWOT ANALYSIS